SCHEMBL546913

SCHEMBL546913

NC(=O)C1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492294 1.00
SCHEMBL18474377 1.00
Phosphine SCHEMBL27998527 0.98 NOS2 (0.50)
Methane SCHEMBL27493565 0.98 NOS2 (0.50)
Hydrochloric Acid SCHEMBL5418246 0.98 NOS2 (0.50)
Ammonia Solution, Strong SCHEMBL27413104 0.98 NOS2 (0.50)
SCHEMBL840224 0.98 NOS2 (0.50)
Ethane SCHEMBL27994756 0.96 NOS2 (0.48)
Ammonia Solution, Strong SCHEMBL28000860 0.96 NOS2 (0.48)
Ammonia Solution, Strong SCHEMBL28838077 0.96 NOS2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291556-A1 HYDROXYHETEROCYCLOALKANE-CARBAMOYL DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2023-12-20 EP claimed
EP-4237419-A1 GALECTIN-3 INHIBITING 2-HYDROXYCYCLOALKANE-1 -CARBAMOYL DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2023-09-06 EP claimed
US-20220402983-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES JANSSEN BIOTECH, INC. 2022-12-22 US claimed
WO-2022171594-A1 HYDROXYHETEROCYCLOALKANE-CARBAMOYL DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2022-08-18 WO claimed
EP-4013751-A1 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2022-06-22 EP claimed
WO-2022090544-A1 GALECTIN-3 INHIBITING 2-HYDROXYCYCLOALKANE-1 -CARBAMOYL DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2022-05-05 WO claimed
CN-114269737-A 2-hydroxycycloalkane-1-carbamoyl derivatives 爱杜西亚药品有限公司 2022-04-01 CN claimed
US-20210361642-A1 WASP-PROTECTING SMALL MOLECULES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF INNATE AND ACQUIRED IMMUNE-RELATED DISORDERS OR CONDITIONS BAR ILAN UNIVERSITY (IL) 2021-11-25 US claimed
CN-108047157-A The method of one-step synthesis 2- amino benzoxazoles heterocyclic compounds 江苏欣诺科催化剂有限公司 2018-05-18 CN claimed
CN-107382808-A The preparation method of aza cyclo-butanone derivatives 凯莱英医药化学(阜新)技术有限公司 2017-11-24 CN claimed
CN-1425297-A Nicosulfuron herbicide composition MA YUNSHENG (CN) 2003-06-25 CN claimed
CN-1361776-A Fluorinated imidazoline benzodioxans, their preparation and their therapeutic use PF MEDICAMENT (FR) 2002-07-31 CN claimed
EP-1150565-A1 THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION bioscience AG (DE) 2001-11-07 EP claimed
EP-1126833-A2 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2001-08-29 EP claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
WO-2000045635-A1 THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2000-08-10 WO claimed
WO-2000025768-A1 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2000-05-11 WO claimed
US-4557934-A ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE THE PROCTER & GAMBLE COMPANY (US) 1985-12-10 US claimed